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INTRODUCTION AND AIMS OF THE STUDY 
 
 The skin represents the first line of defence against invading microorganisms. 
Epithelial cells, considered as semi-professional immune cells, express a series of receptors 
known as Pattern Recognition Receptors (PRRs), which recognize distinct pathogen-
associated molecular patterns (PAMPs). Activation of PRRs – for example Toll-like receptors 
(TLRs) – induces the secretion of different antimicrobial peptides (AMPs) and 
proinflammatory mediators resulting in local inflammation. Furthermore, the migration of 
different professional immune cells (e.g. dendritic cells, macrophages, T-cells) at the site of 
infection initiates, among other, adaptive immune response. Importantly, innate immunity 
must be properly controlled, as its continuous activation leads to the development of chronic 
inflammatory diseases. Although our knowledge regarding the direct role of different 
regulatory mechanisms controlling innate immune response is expanding, further 
investigations are needed in order to develop effective therapeutic procedures against chronic 
inflammatory diseases.  
 
With respect to this, aims of this study were as follows: 
 
1. Establishment of an in vitro experimental model for the examination of gene-specific 
regulatory mechanisms of innate immune processes that can be used for monitoring both 
acute and persistent inflammation. 
2. To study the gene expression profile of different proinflammatory cytokines/chemokines 
and AMPs in keratinocytes treated with Staphylococcus aureus-derived peptidoglycan (PGN) 
using the above established model.  
3. To investigate the global level of histone acetylation, a modification associated with 
transcriptional activation in keratinocytes after PGN stimulation/restimulation. 
4., To study the expression profiles of microRNAs (miRNAs) – especially miR-203 and its 
targets (p63, SOCS3) – involved in the posttranscriptional regulatory mechanisms in 
keratinocytes, by utilizing to power of our experimental model. 
5. To investigate the gene- and protein expression profile of TAM receptors and their ligand 
(GAS6) – which are negative regulators of inflammation – in both professional and semi-
professional immune cells, after their immune activation achieved by different microbial 
agents. 
 
 6. To study the expression profile of TAM receptors and GAS6 in psoriasis, a common 
chronic skin disease. 
 
 
METHODS 
 
Cell cultures 
 
 In our experiments immortalized HaCaT human keratinocytes, PK E6/E7 cells 
(vaginal epithelial cells) and primary keratinocytes (pKC) were used as semi-professional 
immune cells. 
 Studying different professional immune cells, on the one hand peripheral blood 
mononuclear cells (PBMCs) were isolated from buffy coat, which cells were treated for 5 
days with granulocyte-macrophage colony stimulating factor (GM-CSF; Sigma) and 
recombinant human interferon- (IFN- Sigma) for differentiation to immature dendritic 
cells (DCs).  To create mature DCs, immature DCs were treated with recombinant human 
TNF- (R&D Systems) for additional day. 
 On the other hand, THP-1 cells (human acute leukemia monocyte) were investigated, 
where activation of THP-1 cells was carried out with addition of phorbol myristyl acetate 
(PMA; Sigma) for 48 hours. 
 
 In each case, cells were cultured at 37 
o
C and 5% CO2 under standard cell culture 
conditions; the cells were used at 60-70% of confluency. 
 
Treatment of cell cultures 
 
 In our experiments stimulations of different cell types were made with the following 
microbial agents: 
- PGN: Staphylococcus aureus-derived peptidoglycan (TLR2 ligand; Fluka) 
- LPS: Escherichia coli-derived lipopolysaccharide (TLR4 ligand; Sigma) 
- Poly I:C: polyinosine-polycytidylic acid as viral double strand RNA synthetic analog (TLR3 
ligand; Enzo Life Sciences) 
 
  Studying the PGN-induced chromatin modification a part of HaCaT cells was treated 
with Trichostatin A (TSA, Sigma), a histone deacetylase (HDAC) inhibitor 2 hours prior to 
PGN stimulation, as well as 24 hours after PGN infection. 
 
Transfection of cells 
 
 HaCaT cells were transfected with specific anti-miR-203 miRNA inhibitor or anti-miR 
negative control constructs using siPORT
TM
 Polyamine-Based Transfection Agent (Life 
Technologies) according to the manufacturer’s „pre-plated” protocol instructions. Transfected 
cells were cultured at 37 
o
C under standard cell culture conditions. 24 hours after the first 
treatment, the transfection was repeated in order to ensure the constant presence of the anti-
miR inhibitor. 
 
RNA extraction 
 
 After the appropriate treatments total RNA was isolated with the RNeasy Mini Plus 
Kit (Qiagen) according to the manufacturer’s protocol. The quantity and quality of total 
RNAs were measured by NanoDrop, Qubit and Bioanalyzer. 
 
Reverse transcription and quantitative real-time PCR 
 
 After quantification and qualification of RNA sample cDNA was synthesized with 
High Capacity RNA to cDNA Kit (Life Technologies) by using Applied Biosystems Veriti 
Thermal Cycler. The expression level of selected genes was determined with ABI StepOne 
Plus Real-Time PCR instrument using TaqMan Gene Expression Assays along with TaqMan 
Gene Expression Master Mix (Life Technologies). The ratio of each mRNA relative to the 
18S rRNA was calculated using the 2
ΔΔC
T method. 
 The expression patterns of miRNAs were determined by TaqMan MicroRNA Reverse 
Transcription Kit and TaqMan MicroRNA Assays (LifeTechnologies) according to the 
manufacturer’s instructions. The ratio of each miRNA relative to RNU48 (Life Technologies) 
was calculated using the 2
ΔΔC
T method. 
All experiments were carried out in at least three independent replicates with two 
technical parallels. 
 
 
 Histone extraction 
 
 To study the effect of different microbial agents on the global histone acetylation 
level, we used the Abcam histone acid extraction protocol. After acid extraction at 4 
o
C 
overnight, concentrations of histone proteins were quantified from supernatants by NanoDrop. 
 
ELISA method 
 
 The amounts of secreted cytokines (IL-6 and CXCL8) were quantified from culture 
supernatants using the Quantikine Single Analyte ELISArray Kit (R&D Systems). Serial 
dilutions of recombinant human IL-6 and CXCL8 were used to generate standard curves. The 
optical density of the wells was determined using a Microtitre Plate Reader (FluoStar Optima, 
BMG Labtech) set to a wavelength of 450 nm, with a wavelength correction set to 570 nm.
  
Total protein extraction 
 
 Harvested cells were homogenized in PBS containing proteinase inhibitor (PIC) and 
phenylmethanesulfonyl fluoride (PMSF). Samples were frozen quickly in liquid nitrogen and 
were thawed slowly on ice by gentle vortexing. This procedure was repeated 3-4 times. 
Samples were than centrifuged, pellets were discarded and total protein concentrations of 
supernatants were determined by NanoDrop. 
 
Western blot 
 
 For quantitative protein analysis equivalent amounts of total- or histone proteins were 
electrophoresed by Tris-SDS-PAGE and transferred to Pure Trans-Blot Transfer Medium 
Nitrocellulose Membrane (Bio-Rad). The successful blotting was confirmed with Ponceau 
staining. The expression profiles of selected proteins were determined by using specific 
primary antibodies. Chemiluminescent detection was performed using appropriate IgG-HRP 
(Bio-Rad) and Immobilon Western Chemiluminescent HRP Substrates (Millipore). 
 
Immunofluorescent labelling 
 
For immunofluorescent detection of investigated proteins cells were grown on 
flexiPERM (Sarstedt) subdividing slides using silicone inserts. After fixation with 
 paraformaldehyde cells were incubated with primary antibodies at 4 
o
C overnight. On the next 
day samples were incubated with the appropriate secondary fluorescein isothiocyanate 
(FITC)/ tetramethyl rhodamine isothiocyanate (TRITC) -conjugated antibodies for 1 hour at 
room temperature. The nuclei of the cells were labeled with 4’,6-diamidino-2-phenylindole 
(DAPI). Samples were mounted with Citifluor (Citifluor Ltd.) to prevent quenching and the 
images were captured with a Zeiss Axio Observer Z1 fluorescent microscope. 
 
RNA extraction from psoriatic and healthy skin biopsies 
 
 Shave biopsies from uninvolved and involved skin of psoriatic patients and control 
skin biopsies were collected,epidermis was separated from the dermis following an overnight 
incubation at 4 °C in Dispase solution (Roche Diagnostics). On the next day samples were 
vortexed vigorously in TRIzol Reagent (Life Technologies) containing chloroform (Sigma). 
After removing the genomic DNA from supernatant (RNeasy Plus Mini Kit, Qiagen), further 
steps (e.g. purification and quantification of total RNA, reverse transcription and quantitative 
real-time PCR) were performed as described above. 
 All tissue samples were taken with the patient's written informed consent and the 
approval of the local ethics committee; the study was conducted according to the Declaration 
of Helsinki Principles.  
  
 
RESULTS 
 
 First, we found in our in vitro experimental model, that the gene expression profile of 
different proinflammatory cytokines/chemokines and AMPs is differently altered when 
keratinocytes are stimulated or restimulated with Staphylococcus aureus-derived 
peptidoglycan (PGN). The expression of cytokines/chemokines (e.g. IL-6, CXCL8) remains 
unchanged upon PGN restimulation, these genes are therefore considered non-tolerizable; in 
contrast, PGN restimulation significantly decreases AMP expression (e.g. DEFB4, CAMP) - 
these genes are considered tolerizable. However, this non-tolerizable/tolerizable phenotype is 
altered when TSA, a HDAC inhibitor pretreatment is applied: the expression of 
proinflammatory mediators is silenced and AMPs are reactivated. 
 These observations prompted us to investigate the role of epigenetic factors (e.g. 
histone acetylation), miRNAs and negative regulatory molecules in the regulation of innate 
 immunity by using our in vitro model. In order to identify mechanisms underlying non-
tolerizable/tolerizable phenotype, first we examined the global level of histone acetylation, a 
modification associated with transcriptional activation. We found that PGN 
stimulation/restimulation differentially influences the acetylation levels of H3 and H4 histone 
proteins. These global epigenetic changes - which can specifically modify the gene expression 
are, partly, responsible for the tolerization of innate immune system.  
 By investigating the posttranscriptional effect of PGN stimulation/restimulation in 
keratinocytes we found that miR-146a and miR-155 miRNAs show non-tolerizable 
phenotype; in contrast, the keratinocyte-specific miR-203 is tolerizable. Furthermore, the 
expression profiles of miR-203 and its target proteins p63 and SOCS3) change in opposite 
directions, showing the immediate role of miR-203 in the posttranscriptional regulation of its 
targets. 
 By studying the expression profile of the TAM receptor family members, which is a 
negative feedback regulators of  innate immune processes, we found that the expression of 
these receptors is altered in several cell types (e.g. dendritic cells, monocytes, vaginal 
epithelial cells, keratinocytes) as a response to treatment with different microbial agents. Our 
data are showing that the expression pattern of TAMs upon challenge with different microbial 
agents negatively correlates with thatof pro- inflammatory mediators: in parallel with the 
downregulation of TAMs the expression of proinflammatory mediators (e.g. TNF-, IL-6) is 
upregulated.  
 Finally, in order to test our observations made in the in vitro experimental model, we 
studied the expression profile of TAM receptor family in vivo in samples from psoriatic 
patients. We found that the expression of TAM receptors remarkably decreases in the 
epidermis of diseased patients. Importantly, this down-regulated gene expression is present 
both in lesional and non-lesional epidermis of psoriatic patients. Furthermore, down-regulated 
expression of TAMs and their ligand (GAS6) is associated with significant up-regulation of 
proinflammatory mediators (e.g. TNF-, CXCL8), pointing toward a possible regulatory role 
of TAM receptors in skin immune processes. 
  Summarizing the results we can conclude, that our in vitro experimental model is 
suitable to study different gene-specific regulatory mechanisms responsible for controlling 
acute and persistent infection. 
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